DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 018686
The generic ingredient in NORMODYNE is labetalol hydrochloride. There are fourteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the labetalol hydrochloride profile page.
Summary for 018686
Tradename: | NORMODYNE |
Applicant: | Schering |
Ingredient: | labetalol hydrochloride |
Patents: | 0 |
Therapeutic Class: | Cardiovascular Agents |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 018686
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/ML | ||||
Approval Date: | Aug 1, 1984 | TE: | RLD: | No |
Expired US Patents for NDA 018686
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | NORMODYNE | labetalol hydrochloride | INJECTABLE;INJECTION | 018686-001 | Aug 1, 1984 | ➤ Sign Up | ➤ Sign Up |
Schering | NORMODYNE | labetalol hydrochloride | INJECTABLE;INJECTION | 018686-001 | Aug 1, 1984 | ➤ Sign Up | ➤ Sign Up |
Schering | NORMODYNE | labetalol hydrochloride | INJECTABLE;INJECTION | 018686-001 | Aug 1, 1984 | ➤ Sign Up | ➤ Sign Up |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Complete Access Available with Subscription